Dominant-Negative Androgen Receptor Inhibition of Intracrine Androgen-Dependent Growth of Castration-Recurrent Prostate Cancer

• Mark A. Titus ,

  Contributed equally to this work with: Mark A. Titus, Brian Zeithaml, James L. Mohler, Tal Kafri

  Affiliation Department of Urology, Roswell Park Cancer Institute, Buffalo, New York, United States of America

  ⨯
• Brian Zeithaml ,

  Contributed equally to this work with: Mark A. Titus, Brian Zeithaml, James L. Mohler, Tal Kafri

  Affiliation UNC Gene Therapy Center, School of Medicine, University of North Carolina, Chapel Hill, North Carolina, United States of America

  ⨯
• Boris Kantor,

  Affiliations UNC Gene Therapy Center, School of Medicine, University of North Carolina, Chapel Hill, North Carolina, United States of America, Lineberger Comprehensive Cancer Center, School of Medicine, University of North Carolina, Chapel Hill, North Carolina, United States of America

  ⨯
• Xiangping Li,

  Affiliation UNC Gene Therapy Center, School of Medicine, University of North Carolina, Chapel Hill, North Carolina, United States of America

  ⨯
• Karin Haack,

  Affiliation UNC Gene Therapy Center, School of Medicine, University of North Carolina, Chapel Hill, North Carolina, United States of America

  ⨯
• Dominic T. Moore,

  Affiliation Lineberger Comprehensive Cancer Center, School of Medicine, University of North Carolina, Chapel Hill, North Carolina, United States of America

  ⨯
• Elizabeth M. Wilson,

  Affiliations Laboratories for Reproductive Biology, School of Medicine, University of North Carolina, Chapel Hill, North Carolina, United States of America, Lineberger Comprehensive Cancer Center, School of Medicine, University of North Carolina, Chapel Hill, North Carolina, United States of America, Department of Pediatrics, School of Medicine, University of North Carolina, Chapel Hill, North Carolina, United States of America, Department of Biochemistry and Biophysics, School of Medicine, University of North Carolina, Chapel Hill, North Carolina, United States of America

  ⨯
• James L. Mohler ,

  Contributed equally to this work with: Mark A. Titus, Brian Zeithaml, James L. Mohler, Tal Kafri

  Affiliations Department of Urology, Roswell Park Cancer Institute, Buffalo, New York, United States of America, Department of Urology, School of Medicine and Biotechnology, University at Buffalo, Buffalo, New York, United States of America, Lineberger Comprehensive Cancer Center, School of Medicine, University of North Carolina, Chapel Hill, North Carolina, United States of America

  ⨯
• Tal Kafri

  Contributed equally to this work with: Mark A. Titus, Brian Zeithaml, James L. Mohler, Tal Kafri

  * E-mail: Tal_Kafri@med.unc.edu

  Affiliations UNC Gene Therapy Center, School of Medicine, University of North Carolina, Chapel Hill, North Carolina, United States of America, Lineberger Comprehensive Cancer Center, School of Medicine, University of North Carolina, Chapel Hill, North Carolina, United States of America, Department of Microbiology and Immunology, School of Medicine, University of North Carolina, Chapel Hill, North Carolina, United States of America

  ⨯